The hardware and bandwidth for this mirror is donated by METANET, the Webhosting and Full Service-Cloud Provider.
If you wish to report a bug, or if you are interested in having us mirror your free-software or open-source project, please feel free to contact us at mirror[@]metanet.ch.

Simulation trials: non-proportional hazard

Introduction

We can use objects of the class SURVIVAL to simulate surviving times in clinical trials. We present in this example the evaluation of empirical power to detect non proportionality of the hazard.

In this example, simulation of the survival times in the control group follows a Weibull distribution with shape 0.8 (negative) and a failure rate of 0.6 at month 12. The experimental group have a vaccine efficacy of 80% during the first month, but it decrease linearly to 10% at month 12. We simulate survival times in the experimental group using a piecewise exponential distribution with changes each month to follow the linear decrease of vaccine efficacy.

The empirical power is define as the percentage the test for non-proportionality p-value is lower or equal than 0.05

library(survobj)
library(survival)

Empirical power to evaluate non proportionality of the hazard

Assumptions:


# Number of simulations
nsim = 1000

# Participants in each group
nsubjects = 250

# Follow-up time
ftime <- 12

# Vaccine efficacy
ve_start = 80
ve_end = 10

# Hazard ratio
hr <- function(t){
  vm <- ve_start - (ve_start-ve_end)/(ftime-1)*(t-1)
  1-vm/100
}

# Fail events in controls 
fail_control = 0.4

# Define Object with weibull distribution for events in controls
s_ctrl <- s_weibull(fail = fail_control, t = ftime, shape = 0.8)


# Define Object with Picewise exponential distribution in vaccinated

s_vacc <- s_piecewise(
            breaks = c(1:12,Inf), 
            hazards = c(s_ctrl$hfx(1:12)*hr(1:12), s_ctrl$hfx(12)*hr(12)))

The following graph compare the two distributions

compare_survival(s_ctrl, s_vacc, timeto = 12)

Simulation

set.seed(12345)

# Define the group for the subjects
group = c(rep(0, nsubjects), rep(1, nsubjects))
    

# Loop    
sim <- lapply(
  1:nsim,
  function(x){
    # Simulate survival times for event
    # Using one distribution for the controls and other for the vaccinated
    sim_time_event <- c(s_ctrl$rsurv(nsubjects), s_vacc$rsurv(nsubjects))
    
    # Censor events at end of follow-up.
    cevent <- censor_event(censor_time = ftime, time = sim_time_event, event = 1)
    ctime <- censor_time(censor_time = ftime, time = sim_time_event)
    
    # Analyze the data using cox regression
    reg <- coxph(Surv(ctime, cevent)~ group)
    sreg <- summary(reg)
    phz <- cox.zph(reg)
    
    # Collect the information
    pval = phz$table["group","p"]
    ve = (1- exp(sreg$coefficients["group","coef"]))*100
    nevents = sreg$nevent
    
    # return values
    return(data.frame(simid = x, pval,ve, nevents))
  }
)

# Join all the simulations in a single data frame
sim_df <- do.call(rbind, sim)

Analyze the simulation

empirical_power = binom.test(sum(sim_df$pval <= 0.05), length(sim_df$pval))
empirical_power$estimate
#> probability of success 
#>                  0.839
empirical_power$conf.int
#> [1] 0.8147291 0.8612550
#> attr(,"conf.level")
#> [1] 0.95

# Distribution of the simulated VE estimated under PH assumpation
summary(sim_df$ve)
#>    Min. 1st Qu.  Median    Mean 3rd Qu.    Max. 
#>   23.74   47.63   52.98   52.32   57.82   72.81

# Distribution of the simulated number of events
summary(sim_df$nevents)
#>    Min. 1st Qu.  Median    Mean 3rd Qu.    Max. 
#>     126     149     156     156     163     184

Conclusion

The simulation provides an estimate of the empirical power to reject the proportionality of the hazard assumption in this condition as 83.9% with a 95%CI of ( 81.5%, 86.1% )

References

GRAMBSCH, PATRICIA M., and TERRY M. THERNEAU. 1994. “Proportional Hazards Tests and Diagnostics Based on Weighted Residuals.” Biometrika 81 (3): 515–26. https://doi.org/10.1093/biomet/81.3.515.

These binaries (installable software) and packages are in development.
They may not be fully stable and should be used with caution. We make no claims about them.